| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| dostarlimab and endometrial cancer | 1.7 | 0.9 | 3400 | 10 | 34 |
| dostarlimab | 0.08 | 0.1 | 2779 | 78 | 11 |
| and | 0.91 | 0.5 | 6025 | 56 | 3 |
| endometrial | 1.72 | 0.7 | 9804 | 29 | 11 |
| cancer | 0.5 | 0.8 | 8708 | 85 | 6 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| dostarlimab and endometrial cancer | 0.32 | 0.1 | 1408 | 81 |
| endometrial cancer dostarlimab | 1.23 | 0.4 | 9345 | 93 |
| dostarlimab endometrial cancer fda approval | 2 | 0.5 | 6858 | 61 |
| dostarlimab endometrial cancer fda | 1.74 | 0.3 | 8851 | 42 |
| dostarlimab endometrial cancer nejm | 0.24 | 0.7 | 2512 | 81 |
| dostarlimab endometrial cancer garnet | 1.39 | 0.4 | 5375 | 94 |
| nice dostarlimab endometrial cancer | 0.91 | 0.2 | 4687 | 95 |
| dostarlimab for endometrial cancer | 1.74 | 0.2 | 8862 | 35 |
| garnet trial endometrial cancer | 0.21 | 0.8 | 8538 | 55 |
| garnet study endometrial cancer | 1.02 | 1 | 8750 | 65 |
| dostarlimab chemotherapy endometrial cancer | 1.2 | 0.3 | 6566 | 47 |
